1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
Cancer Biomarkers Market by Type, Cancer Type, Profiling Technology, Application - Global Forecast to 2022

Cancer Biomarkers Market: Global Forecast until 2022

  • October 2017
  • 251 pages
  • ID: 5139366
In this report:
According to OECD, a total of ##,## new cancer cases (excluding nonmelanoma skin cancer) were reported in 2012, and this number is expected to reach ##,## by 2020, representing an increase of ##%.
The global cancer biomarkers market was valued at USD ##.## billion in 2017, and is expected to record a CAGR of ##.##% during the forecast period, to reach USD ##.## billion by 2022.


Table of Contents

Search Inside

Global cancer biomarkers market forecasted to grow at Compound annual growth rate of 12.20 percent

The overall cancer biomarkers market is estimated to grow ~$20.5B by 2022 from ~$11.5B in 2017, at a compound annual growth rate (CAGR) of 12.20 percent between 2017 and 2022.

Over the years, the cancer biomarkers market has evolved significantly due to the growing prevalence of cancer, advancements in omics technologies, growing healthcare expenditure, increase in R&D funding from government and private bodies, and increasing demand for personalized medicine in cancer therapies. Nevertheless, an unfavorable regulatory and reimbursement scenario and the high capital investments required for biomarker development and validation are some factors anticipated to restrain the sector.

The lung cancer segment is projected to record the maximal CAGR (Compound annual growth rate)'

The cancer biomarkers market based on cancer type is categorized into breast, lung, colorectal, prostate, melanoma, leukemia, thyroid, bladder, non-hodgkin's lymphoma, kidney, and other cancers.The lung cancer segment is expected to record the maximal compound annual growth rate (CAGR) during the outlook period.

The rising company focus on industry research on lung cancer biomarkers is the main driver for this industry. Increased understanding of the morphology of lung carcinogenesis, development of the high-throughput techniques for biomarker discovery, and rised focus on early detection of cancer are propelling the increase of this market.

North America continent is forecasted to dominate the cancer biomarkers market and Asia-Pac increasing at the highest CAGR (Compound annual growth rate)

North America (NA) (comprising the USA and Canada (CA)) is forecasted to account for the biggest share of the overall cancer biomarkers market in 2017.The big share of this geographic segment is essentially attributed to the growing government support for discovery and development of biomarkers, growing demand for personalized medicine, adoption of advanced omics technologies for biomarker discovery, and growing use of biomarkers in drug discovery and development by pharmaceutical companies in that area.

While the APAC area is forecast to register the highest compound annual growth rate (CAGR) during the estimate period. The APAC cancer biomarkers market, particularly in China, Japan (JP), and India (IN) is anticipated to witness high increase during the outlook period.

Break of primary members taking part was as mentioned below:

• By Company category - Tier 1 - 40.0 percent, Tier 2 - 30.0 percent, and Tier 3 - 30.0 percent

• By Description - D-level - 18.0 percent, C-suite - 27.0 percent, and Others - 55.0 percent

• By Area - North America continent - 50.0 percent, Europe (EU) - 20.0 percent, Asia Pacific (APAC) - 20.0 percent, and rest of the world - 10.0 percent

Top actors in this sector that are profiled in the market research includes Abbott, Affymetrix, Roche, Illumina, QIAGEN, Agilent, Thermo Fisher, Merck, Becton Dickinson, Hologic, Danaher, and Shimadzu.

Segment Research

From an insight prospect, this market research highlights on qualitative data, market value, and rise of several segments and sub-segments, opposing landscape, and company descriptions.The qualitative data contains different levels of industry analysis including market dynamics (drivers, market restraints, alternatives, and opportunities).

The industry report also provides market values and info on the increase of several segments of the sector.It focuses on emerging and the high-development segments, and high-growth areas.

The competitive landscape includes increase strategies approved by sector actors in the last three years.The corporation reviews include basic views on key competitors in the cancer biomarkers market and the product types, advancements, and strategies approved by market actors to maintain and rise their market shares in the upcoming future.

The above-mentioned segment research data, current market size, and projection of future trends will facilitate top players and new sector entrants to make the essential decisions regarding product offerings, spatial focus, change in approach, Research and development investments for modernizations in products and technologies, and levels of output to remain profitable.

Why acquiring this study can help you:

The study will increase established companies as well as new entrants/smaller companies to measure the pulse of the sector, which in turn would help garner a greater share. Companies obtaining the analysis could use one or any combination of the below-mentioned five strategies.

This study furnishes highlights on the following points:

• Market Uptake: Exhaustive data on products provided by the top actors in the cancer biomarkers market

• Product/Service Enhancement/Innovative products: In-depth understanding on the next technologies, analysis & growth activities, and recent product launches in the cancer biomarkers market

• Market Development: Highlighted information about lucrative emerging markets-the report examines the industries for profiling technologies across several areas

• industry diversification: Complete information about recent products, untapped areas, and recent evolutions in the cancer biomarkers market

• opposing assessment: In-depth assessment of market ranking, strategies, products, and manufacturing competences of the key players in the cancer biomarkers market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Nicolas helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Biomarker Technologies Market by Profiling, Research Area, Application - Global Forecast to 2022

Biomarker Technologies: Global Forecast until 2022

  • $ 5650
  • Industry report
  • May 2018
  • by MarketsandMarkets

The biomarker technologies market is projected to grow at a CAGR of 9.7%.The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% ...

Breakthroughs in Leveraging Biomarkers for Oncology

Breakthroughs in Leveraging Biomarkers for Oncology

  • $ 4950
  • Industry report
  • September 2017
  • by Frost & Sullivan

Accelerating Solutions for Cancer Diagnostics and TherapeuticsPredictive biomarkers are used to provide the best treatment indication with the greater probability of response to a certain specific chemotherapeutic ...

The 2019-2024 World Outlook for Cancer Biomarkers

The 2019-2024 World Outlook for Cancer Biomarkers

  • $ 995
  • Industry report
  • January 2018
  • by ICON Group

This study covers the world outlook for cancer biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ...

Global Cancer Biomarkers Market $ 4250 February 2018


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on